Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
10.1016/j.biomaterials.2008.04.036
Crossref journal-article
Elsevier BV
Biomaterials (78)
Bibliography

Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J.-P. (2008). Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials, 29(24–25), 3477–3496.

Authors 5
  1. Marie Morille (first)
  2. Catherine Passirani (additional)
  3. Arnaud Vonarbourg (additional)
  4. Anne Clavreul (additional)
  5. Jean-Pierre Benoit (additional)
References 296 Referenced 664
  1. 10.1016/j.ccr.2004.11.004 / Cancer Cell / Somatic alterations in the human cancer genome by Weir (2004)
  2. 10.2174/156652306776359496 / Curr Gene Ther / Gene therapy for cystic fibrosis airway disease – is clinical success imminent? by Anson (2006)
  3. 10.1002/jgm.619 / J Gene Med / Gene therapy clinical trials worldwide 1989–2004 – an overview by Edelstein (2004)
  4. {'issue': '11', 'key': '10.1016/j.biomaterials.2008.04.036_bib4', 'first-page': '949', 'article-title': 'Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model', 'volume': '1', 'author': 'Shi', 'year': '2002', 'journal-title': 'Mol Cancer Ther'} / Mol Cancer Ther / Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model by Shi (2002)
  5. 10.1016/S0003-2697(03)00244-6 / Anal Biochem / Stability analysis for long-term storage of naked DNA: impact on nonviral in vivo gene transfer by Walther (2003)
  6. 10.1016/S0939-6411(03)00155-3 / Eur J Pharm Biopharm / Chitosan–DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy by Mansouri (2004)
  7. 10.1016/j.jconrel.2003.09.013 / J Controlled Release / An overview of current delivery systems in cancer gene therapy by El-Aneed (2004)
  8. 10.1126/science.3287617 / Science / Retroviruses by Varmus (1988)
  9. 10.3349/ymj.1994.35.1.1 / Yonsei Med J / Expression and localization of human papillomavirus type 16 E6 and E7 open reading frame proteins in human epidermal keratinocyte by Kim (1994)
  10. {'key': '10.1016/j.biomaterials.2008.04.036_bib10', 'first-page': '97', 'article-title': 'Use of adeno-associated virus as a general transduction vector for mammalian cells', 'volume': '158', 'author': 'Muzyczka', 'year': '1992', 'journal-title': 'Curr Top Microbiol Immunol'} / Curr Top Microbiol Immunol / Use of adeno-associated virus as a general transduction vector for mammalian cells by Muzyczka (1992)
  11. 10.1093/nar/27.19.3792 / Nucleic Acids Res / Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency by Kreiss (1999)
  12. 10.1016/S0142-9612(02)00507-0 / Biomaterials / Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan–DNA nanoparticles by Corsi (2003)
  13. 10.1016/S1359-6446(02)02243-2 / Drug Discov Today / Targeting tumors with non-viral gene delivery systems by Ogris (2002)
  14. 10.1038/sj.gt.3302838 / Gene Ther / Gene therapy progress and prospects: non-viral gene therapy by systemic delivery by Li (2006)
  15. 10.1016/S0169-409X(02)00046-7 / Adv Drug Deliv Rev / Prospects for cationic polymers in gene and oligonucleotide therapy against cancer by Merdan (2002)
  16. 10.1097/00001813-200104000-00001 / Anticancer Drugs / Non-viral vectors in cancer gene therapy: principles and progress by Schatzlein (2001)
  17. 10.1073/pnas.89.23.11277 / Proc Natl Acad Sci U S A / Aerosol gene delivery in vivo by Stribling (1992)
  18. 10.3109/10611860008996855 / J Drug Target / Block and graft copolymers and NanoGel copolymer networks for DNA delivery into cell by Lemieux (2000)
  19. 10.1097/00006123-199704000-00028 / Neurosurgery / Cellular and molecular neurosurgery: pathways from concept to reality, part II: vector systems and delivery methodologies for gene therapy of the central nervous system by Zlokovic (1997)
  20. 10.1038/sj.gt.3300900 / Gene Ther / PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery by Ogris (1999)
  21. 10.1002/jgm.775 / J Gene Med / Gene delivery with low molecular weight linear polyethylenimines by Breunig (2005)
  22. 10.1073/pnas.92.16.7297 / Proc Natl Acad Sci U S A / A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine by Boussif (1995)
  23. 10.1023/A:1014861900478 / Pharm Res / A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity by Fischer (1999)
  24. 10.1021/bc0100455 / Bioconjugate Chem / Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine by Gosselin (2001)
  25. 10.1021/bc990025r / Bioconjugate Chem / Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA by Wolfert (1999)
  26. 10.1016/S0021-9258(18)61209-8 / J Biol Chem / Receptor-mediated in vitro gene transformation by a soluble DNA carrier system by Wu (1987)
  27. 10.1016/S0167-4781(98)00274-7 / Biochim Biophys Acta / Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver by Kwoh (1999)
  28. 10.1182/blood.V97.8.2221 / Blood / Systemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy by Ward (2001)
  29. 10.1023/A:1007552007765 / Pharm Res / Biodegradable polyester, poly[alpha-(4-aminobutyl)-l-glycolic acid], as a non-toxic gene carrier by Lim (2000)
  30. 10.1038/sj.gt.3301334 / Gene Ther / Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice by Koh (2000)
  31. 10.1006/mthe.2001.0459 / Mol Ther / Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice by Ko (2001)
  32. 10.1016/S0168-3659(02)00278-X / J Controlled Release / Immersion delivery of plasmid DNA. II. A study of the potentials of a chitosan based delivery system in rainbow trout (Oncorhynchus mykiss) fry by Romoren (2002)
  33. 10.1016/S0168-3659(03)00126-3 / J Controlled Release / Chitosan-based gastrointestinal delivery systems by Hejazi (2003)
  34. 10.1016/S0169-409X(01)00171-5 / Adv Drug Deliv Rev / Chitosan as a novel nasal delivery system for vaccines by Illum (2001)
  35. 10.1021/bm015548s / Biomacromolecules / Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH by Fang (2001)
  36. 10.1038/sj.gt.3301492 / Gene Ther / Chitosan as a nonviral gene delivery system: structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo by Koping-Hoggard (2001)
  37. 10.1023/A:1011981000671 / Pharm Res / Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability by Erbacher (1998)
  38. 10.1007/BF02975895 / Arch Pharm Res / Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier: in vitro transfection by Park (2004)
  39. 10.1016/S0142-9612(01)00090-4 / Biomaterials / Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines by Thanou (2002)
  40. 10.1016/S0142-9612(01)00111-9 / Biomaterials / Preparation of oxidized glucose-crosslinked N-alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour by Li (2002)
  41. 10.1021/bc015510c / Bioconjugate Chem / Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier by Kim (2001)
  42. 10.1016/S0142-9612(00)00385-9 / Biomaterials / In vitro gene delivery mediated by chitosan: effect of pH, serum, and molecular mass of chitosan on the transfection efficiency by Sato (2001)
  43. 10.1016/j.jconrel.2006.07.021 / J Controlled Release / Development and characterisation of chitosan nanoparticles for siRNA delivery by Katas (2006)
  44. 10.1002/1521-3765(20011105)7:21<4730::AID-CHEM4730>3.0.CO;2-A / Chemistry / Supramolecular solubilisation of hydrophilic dyes by using individual dendritic branches by Dykes (2001)
  45. 10.1093/nar/24.11.2176 / Nucleic Acids Res / Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers by Bielinska (1996)
  46. {'issue': '3–4', 'key': '10.1016/j.biomaterials.2008.04.036_bib46', 'first-page': '339', 'article-title': 'Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers', 'volume': '90', 'author': 'Dennig', 'year': '2002', 'journal-title': 'J Biotechnol'} / J Biotechnol / Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers by Dennig (2002)
  47. 10.1038/sj.gt.3302579 / Gene Ther / Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity by Marano (2005)
  48. 10.1073/pnas.93.10.4897 / Proc Natl Acad Sci U S A / Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers by Kukowska-Latallo (1996)
  49. 10.1021/bc9600630 / Bioconjugate Chem / In vitro gene delivery by degraded polyamidoamine dendrimers by Tang (1996)
  50. 10.1038/sj.gt.3300454 / Gene Ther / The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes by Tang (1997)
  51. {'issue': '4', 'key': '10.1016/j.biomaterials.2008.04.036_bib51', 'first-page': '499', 'article-title': '[In vivo expression of green fluorescent protein gene and immunogenicity of ES312 vaccine both mediated by starburst polyamidoamine dendrimers]', 'volume': '27', 'author': 'Ding', 'year': '2005', 'journal-title': 'Zhongguo Yi Xue Ke Xue Yuan Xue Bao'} / Zhongguo Yi Xue Ke Xue Yuan Xue Bao / [In vivo expression of green fluorescent protein gene and immunogenicity of ES312 vaccine both mediated by starburst polyamidoamine dendrimers] by Ding (2005)
  52. 10.1073/pnas.84.21.7413 / Proc Natl Acad Sci U S A / Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure by Felgner (1987)
  53. 10.1016/S0021-9258(17)41980-6 / J Biol Chem / Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations by Felgner (1994)
  54. 10.1002/1439-7633(20020902)3:9<852::AID-CBIC852>3.0.CO;2-A / Chembiochem / Combinatorial synthesis of new cationic lipids and high-throughput screening of their transfection properties by Lenssen (2002)
  55. 10.1126/science.275.5301.810 / Science / Structure of DNA–cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes by Radler (1997)
  56. 10.1126/science.281.5373.78 / Science / An inverted hexagonal phase of cationic liposome–DNA complexes related to DNA release and delivery by Koltover (1998)
  57. 10.1074/jbc.M105588200 / J Biol Chem / Phase behavior, DNA ordering, and size instability of cationic lipoplexes: relevance to optimal transfection activity by Simberg (2001)
  58. 10.1016/S0006-3495(00)76396-X / Biophys J / Lipoplex formation under equilibrium conditions reveals a three-step mechanism by Oberle (2000)
  59. 10.1016/S1567-5394(02)00132-9 / Bioelectrochemistry / Cationic lipid–DNA complexes–lipoplexes for gene transfer and therapy by Zhdanov (2002)
  60. {'issue': '10', 'key': '10.1016/j.biomaterials.2008.04.036_bib60', 'first-page': '710', 'article-title': 'Cationic liposome-mediated gene transfer', 'volume': '2', 'author': 'Gao', 'year': '1995', 'journal-title': 'Gene Ther'} / Gene Ther / Cationic liposome-mediated gene transfer by Gao (1995)
  61. 10.1089/hum.1996.7.12-1437 / Hum Gene Ther / Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery by Plank (1996)
  62. 10.1126/science.7687073 / Science / Systemic gene expression after intravenous DNA delivery into adult mice by Zhu (1993)
  63. 10.1007/s00432-001-0318-x / J Cancer Res Clin Oncol / Immunostimulatory activity of cationic-lipid–nucleic-acid complexes against cancer by Dass (2002)
  64. 10.1038/sj.gt.3300482 / Gene Ther / In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes by Li (1997)
  65. 10.1038/sj.gt.3300424 / Gene Ther / Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration by Liu (1997)
  66. 10.1038/nbt0297-167 / Nat Biotechnol / Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery by Liu (1997)
  67. 10.1023/A:1012187414126 / Pharm Res / Cationic lipid-based gene delivery systems: pharmaceutical perspectives by Mahato (1997)
  68. 10.1021/bi00041a033 / Biochemistry / A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery by Solodin (1995)
  69. 10.1038/nbt0797-647 / Nat Biotechnol / Improved DNA: liposome complexes for increased systemic delivery and gene expression by Templeton (1997)
  70. 10.1038/sj.gt.3301460 / Gene Ther / Interaction between DNA–cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid by Sakurai (2001)
  71. 10.1073/pnas.92.21.9742 / Proc Natl Acad Sci U S A / Systemic gene therapy: biodistribution and long-term expression of a transgene in mice by Thierry (1995)
  72. 10.1089/hum.1998.9.14-2083 / Hum Gene Ther / Biodistribution and gene expression of lipid/plasmid complexes after systemic administration by Mahato (1998)
  73. 10.1023/A:1012146305040 / Pharm Res / In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex by Hofland (1997)
  74. {'issue': '5 Pt 1', 'key': '10.1016/j.biomaterials.2008.04.036_bib74', 'article-title': 'Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors', 'volume': '276', 'author': 'Li', 'year': '1999', 'journal-title': 'Am J Physiol'} / Am J Physiol / Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors by Li (1999)
  75. 10.1006/mthe.2002.0598 / Mol Ther / CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo by Yew (2002)
  76. 10.1006/mthe.2001.0266 / Mol Ther / Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector by Ramesh (2001)
  77. 10.1080/08982100500528685 / J Liposome Res / Specific lipoplex-mediated antisense against Bcl-2 in breast cancer cells: a comparison between different formulations by Meidan (2006)
  78. 10.1038/sj.cgt.7700793 / Cancer Gene Ther / Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo by Chien (2005)
  79. 10.1038/nbt1122 / Nat Biotechnol / Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs by Morrissey (2005)
  80. 10.1089/hum.2006.17.117 / Hum Gene Ther / Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery by Pirollo (2006)
  81. 10.1038/sj.cgt.7700753 / Cancer Gene Ther / Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer by Liu (2004)
  82. 10.1158/1078-0432.CCR-04-1049 / Clin Cancer Res / Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer by Yano (2004)
  83. 10.1158/0008-5472.CAN-05-0530 / Cancer Res / Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery by Landen (2005)
  84. 10.1089/hum.2005.16.937 / Hum Gene Ther / Phase I study of liposome–DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases by Dow (2005)
  85. 10.1016/S0169-409X(01)00213-7 / Adv Drug Deliv Rev / Towards synthetic viruses by Zuber (2001)
  86. 10.1038/71889 / Nat Biotechnol / Synthetic DNA delivery systems by Luo (2000)
  87. 10.1002/jgm.225 / J Gene Med / Jet nebulization of PEI/DNA polyplexes: physical stability and in vitro gene delivery efficiency by Rudolph (2002)
  88. {'key': '10.1016/j.biomaterials.2008.04.036_bib88', 'first-page': '313', 'article-title': 'Cloning of cDNA from induced K562 cells which can activate globin gene expression', 'volume': '316A', 'author': 'Wu', 'year': '1989', 'journal-title': 'Prog Clin Biol Res'} / Prog Clin Biol Res / Cloning of cDNA from induced K562 cells which can activate globin gene expression by Wu (1989)
  89. 10.1038/sj.gt.3300484 / Gene Ther / Protamine sulfate enhances lipid-mediated gene transfer by Sorgi (1997)
  90. 10.1038/sj.gt.3300795 / Gene Ther / Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo by Schwartz (1999)
  91. {'issue': '3', 'key': '10.1016/j.biomaterials.2008.04.036_bib91', 'first-page': '353', 'article-title': 'An SV40 large T antigen binding site in the cellular genome is part of a cis-acting transcriptional element', 'volume': '5', 'author': 'Wagner', 'year': '1990', 'journal-title': 'Oncogene'} / Oncogene / An SV40 large T antigen binding site in the cellular genome is part of a cis-acting transcriptional element by Wagner (1990)
  92. 10.1016/S0168-3659(00)00358-8 / J Controlled Release / In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density by Zauner (2001)
  93. 10.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.0.CO;2-Y / J Gene Med / Polycation-based DNA complexes for tumor-targeted gene delivery in vivo by Kircheis (1999)
  94. 10.1016/S0169-409X(02)00044-3 / Adv Drug Deliv Rev / Nanoparticles in cancer therapy and diagnosis by Brigger (2002)
  95. {'key': '10.1016/j.biomaterials.2008.04.036_bib95', 'series-title': 'Biomaterials for delivery and targeting of proteins and nucleic acids', 'first-page': '187', 'article-title': 'Complement activation by injectable colloidal drug carriers', 'author': 'Passirani', 'year': '2005'} / Biomaterials for delivery and targeting of proteins and nucleic acids / Complement activation by injectable colloidal drug carriers by Passirani (2005)
  96. 10.1146/annurev.bi.57.070188.001541 / Annu Rev Biochem / Molecular organization and function of the complement system by Muller-Eberhard (1988)
  97. 10.1126/science.8128245 / Science / Biodegradable long-circulating polymeric nanospheres by Gref (1994)
  98. 10.1016/j.biomaterials.2006.03.039 / Biomaterials / Parameters influencing the stealthiness of colloidal drug delivery systems by Vonarbourg (2006)
  99. 10.1016/S0005-2760(97)00169-0 / Biochim Biophys Acta / Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells by Zelphati (1998)
  100. 10.1038/35099560 / Nature / Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 by Alexopoulou (2001)
  101. 10.1126/science.1093620 / Science / Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 by Heil (2004)
  102. 10.1016/S1074-7613(03)00323-6 / Immunity / Activation of autoreactive B cells by CpG dsDNA by Viglianti (2003)
  103. 10.1089/10430340050207984 / Hum Gene Ther / Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice by Tousignant (2000)
  104. 10.1038/sj.cgt.7700982 / Cancer Gene Ther / Vaccination with liposome–DNA complexes elicits enhanced antitumor immunity by U'Ren (2006)
  105. 10.4049/jimmunol.163.3.1552 / J Immunol / Lipid–DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously by Dow (1999)
  106. 10.1038/sj.gt.3301026 / Gene Ther / LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth by Whitmore (1999)
  107. 10.1073/pnas.081626898 / Proc Natl Acad Sci U S A / Role of tumor–host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors by Pluen (2001)
  108. 10.1177/002215549904700908 / J Histochem Cytochem / Intracellular visualization of BrdU-labeled plasmid DNA/cationic liposome complexes by El Ouahabi (1999)
  109. 10.1023/A:1014212630566 / Pharm Res / Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments by Merdan (2002)
  110. 10.1016/0005-2736(94)90066-3 / Biochim Biophys Acta / DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action by Zhou (1994)
  111. 10.1038/nature01451 / Nature / Regulated portals of entry into the cell by Conner (2003)
  112. 10.1016/j.bbamcr.2005.11.005 / Biochim Biophys Acta / Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers by Kirkham (2005)
  113. 10.1073/pnas.93.22.12349 / Proc Natl Acad Sci U S A / Evidence for the role of proteoglycans in cation-mediated gene transfer by Mislick (1996)
  114. 10.1074/jbc.273.40.26164 / J Biol Chem / Proteoglycans mediate cationic liposome–DNA complex-based gene delivery in vitro and in vivo by Mounkes (1998)
  115. 10.1016/j.ymthe.2005.03.038 / Mol Ther / Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes by Rejman (2005)
  116. 10.1074/jbc.M111257200 / J Biol Chem / Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis by Zuhorn (2002)
  117. 10.1016/S0005-2736(99)00238-2 / Biochim Biophys Acta / Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum by Simoes (2000)
  118. 10.1146/annurev.cellbio.12.1.575 / Annu Rev Cell Dev Biol / Endocytosis and molecular sorting by Mellman (1996)
  119. 10.1038/364639a0 / Nature / Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria by Francis (1993)
  120. 10.1074/jbc.272.2.1117 / J Biol Chem / Loss of binding and entry of liposome–DNA complexes decreases transfection efficiency in differentiated airway epithelial cells by Matsui (1997)
  121. 10.1089/hum.1998.9.7-1037 / Hum Gene Ther / An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery by Harbottle (1998)
  122. 10.1124/pr.58.1.8 / Pharmacol Rev / Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery by Khalil (2006)
  123. 10.1042/bj20031253 / Biochem J / Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis by Rejman (2004)
  124. 10.1021/bc000018z / Bioconjugate Chem / High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model by Zhang (2000)
  125. 10.1085/jgp.117.4.329 / J Gen Physiol / Regulation of organelle acidity by Grabe (2001)
  126. 10.1083/jcb.97.3.929 / J Cell Biol / Acidification of endocytic vesicles by an ATP-dependent proton pump by Yamashiro (1983)
  127. 10.1007/978-1-4684-5442-0_16 / Adv Exp Med Biol / Endosome acidification and the pathways of receptor-mediated endocytosis by Maxfield (1987)
  128. 10.1021/bi9602019 / Biochemistry / Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection by Xu (1996)
  129. 10.1073/pnas.93.21.11493 / Proc Natl Acad Sci U S A / Mechanism of oligonucleotide release from cationic liposomes by Zelphati (1996)
  130. 10.1038/sj.gt.3301506 / Gene Ther / On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids by Hafez (2001)
  131. 10.1021/bi00350a001 / Biochemistry / Destabilization of phosphatidylethanolamine liposomes at the hexagonal phase transition temperature by Ellens (1986)
  132. 10.1002/jgm.173 / J Gene Med / Polyethylenimine-mediated gene delivery: a mechanistic study by Kichler (2001)
  133. 10.1073/pnas.93.18.9682 / Proc Natl Acad Sci U S A / Guanidinium–cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells by Vigneron (1996)
  134. 10.1074/jbc.275.3.1625 / J Biol Chem / Size-dependent DNA mobility in cytoplasm and nucleus by Lukacs (2000)
  135. 10.1038/sj.gt.3300867 / Gene Ther / Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer by Lechardeur (1999)
  136. 10.1074/jbc.273.13.7507 / J Biol Chem / Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells by Pollard (1998)
  137. 10.1073/pnas.92.10.4572 / Proc Natl Acad Sci U S A / Plasmid DNA entry into postmitotic nuclei of primary rat myotubes by Dowty (1995)
  138. 10.1126/science.288.5470.1374 / Science / Gatekeepers of the nucleus by Wente (2000)
  139. 10.1126/science.271.5255.1513 / Science / Nucleocytoplasmic transport by Gorlich (1996)
  140. 10.1016/0092-8674(84)90457-4 / Cell / A short amino acid sequence able to specify nuclear location by Kalderon (1984)
  141. 10.1073/pnas.92.6.2008 / Proc Natl Acad Sci U S A / Previously identified protein of uncertain function is karyopherin alpha and together with karyopherin beta docks import substrate at nuclear pore complexes by Moroianu (1995)
  142. 10.1002/jgm.174 / J Gene Med / Critical assessment of the nuclear import of plasmid during cationic lipid-mediated gene transfer by Escriou (2001)
  143. 10.1006/mthe.2001.0509 / Mol Ther / Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation by Brunner (2002)
  144. 10.1021/bc0001084 / Bioconjugate Chem / Effects of structure of beta-cyclodextrin-containing polymers on gene delivery by Hwang (2001)
  145. 10.1038/271130a0 / Nature / alpha-Helix–double helix interaction shown in the structure of a protamine–transfer RNA complex and a nucleoprotamine model by Warrant (1978)
  146. 10.1007/978-3-642-46294-8_1 / Mol Biol Biochem Biophys / Protamines: isolation, characterization, structure and function by Ando (1973)
  147. 10.1038/sj.gt.3300683 / Gene Ther / Characterization of cationic lipid–protamine–DNA (LPD) complexes for intravenous gene delivery by Li (1998)
  148. {'issue': '22', 'key': '10.1016/j.biomaterials.2008.04.036_bib148', 'first-page': '6712', 'article-title': 'Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene', 'volume': '62', 'author': 'Ueno', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene by Ueno (2002)
  149. 10.1038/sj.cgt.7700743 / Cancer Gene Ther / Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer by Liao (2004)
  150. 10.1038/sj.gt.3301401 / Gene Ther / Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core by Murray (2001)
  151. 10.1038/sj.gt.3301686 / Gene Ther / Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNA by Tagawa (2002)
  152. 10.1038/sj.gt.3301938 / Gene Ther / Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium by Lee (2003)
  153. 10.1016/S0005-2736(03)00027-0 / Biochim Biophys Acta / Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells by Lee (2003)
  154. 10.1021/bi952436a / Biochemistry / Potentiation of cationic liposome-mediated gene delivery by polycations by Gao (1996)
  155. {'issue': '5', 'key': '10.1016/j.biomaterials.2008.04.036_bib155', 'first-page': '396', 'article-title': 'Condensation of\xa0plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells', 'volume': '3', 'author': 'Vitiello', 'year': '1996', 'journal-title': 'Gene Ther'} / Gene Ther / Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells by Vitiello (1996)
  156. 10.1016/S0014-5793(96)01397-X / FEBS Lett / Stabilization of cationic liposome–plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery by Hong (1997)
  157. 10.1089/hum.1996.7.12-1395 / Hum Gene Ther / Gene transfer into mammalian cells using histone-condensed plasmid DNA by Fritz (1996)
  158. 10.1016/0005-2736(96)00106-X / Biochim Biophys Acta / Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation by Hagstrom (1996)
  159. 10.1038/sj.gt.3300577 / Gene Ther / Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: cationic liposomal gene therapy of carcinomatosa by Namiki (1998)
  160. 10.1038/sj.gt.3301095 / Gene Ther / An integrin-targeted non-viral vector for pulmonary gene therapy by Jenkins (2000)
  161. 10.1038/sj.gt.3300760 / Gene Ther / Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells by Colin (1998)
  162. 10.1016/S0304-4165(00)00007-6 / Biochim Biophys Acta / Transfection using synthetic peptides: comparison of three DNA-compacting peptides and effect of centrifugation by Vaysse (2000)
  163. 10.1038/sj.gt.3301294 / Gene Ther / Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes by Chen (2000)
  164. 10.1016/S0169-409X(99)00066-6 / Adv Drug Deliv Rev / Endosomes, lysosomes: their implication in gene transfer by Wattiaux (2000)
  165. 10.1016/j.biomaterials.2003.08.069 / Biomaterials / Preparation and characterization of cationic PLGA nanospheres as DNA carriers by Ravi Kumar (2004)
  166. 10.1016/S0168-3659(01)00397-2 / J Controlled Release / Poly(lactic acid)–poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA by Perez (2001)
  167. 10.1016/j.ijpharm.2005.04.017 / Int J Pharm / Physicochemical characterization of poly(l-lactic acid) and poly(d,l-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier by Kim (2005)
  168. 10.1016/j.ejpb.2004.03.008 / Eur J Pharm Biopharm / PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium by Bivas-Benita (2004)
  169. 10.1111/j.1470-8744.1991.tb00160.x / Biotechnol Appl Biochem / Use of liposomes, viral capsids, and nanoparticles as DNA carriers by Bertling (1991)
  170. 10.1023/A:1015871809313 / Pharm Res / Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides by Chavany (1992)
  171. 10.1016/S0168-3659(97)00246-0 / J Controlled Release / Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides by Fattal (1998)
  172. 10.1023/A:1016017014573 / Pharm Res / Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice by Nakada (1996)
  173. 10.1023/A:1018923301967 / Pharm Res / Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake by Chavany (1994)
  174. 10.1073/pnas.91.22.10460 / Proc Natl Acad Sci U S A / Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice by Schwab (1994)
  175. 10.1089/oli.1.1997.7.483 / Antisense Nucleic Acid Drug Dev / Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides by Zobel (1997)
  176. 10.1023/A:1007582332491 / Pharm Res / Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides by Lambert (2000)
  177. 10.1006/bbrc.2000.3963 / Biochem Biophys Res Commun / EWS fli-1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice by Lambert (2000)
  178. 10.1089/cbr.2005.20.141 / Cancer Biother Radiopharm / Calcium phosphate nanoparticles as a novel nonviral vector for efficient transfection of DNA in cancer gene therapy by Liu (2005)
  179. 10.1089/oli.1.1999.9.301 / Antisense Nucleic Acid Drug Dev / Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides by Aynie (1999)
  180. 10.1021/bc0255586 / Bioconjugate Chem / Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation by Cui (2002)
  181. 10.1016/S0168-3659(01)00506-5 / J Controlled Release / Cationic solid–lipid nanoparticles can efficiently bind and transfect plasmid DNA by Olbrich (2001)
  182. 10.1016/j.ejpb.2005.09.003 / Eur J Pharm Biopharm / Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands by Pedersen (2006)
  183. 10.1016/0014-5793(90)81016-H / FEBS Lett / Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes by Klibanov (1990)
  184. {'issue': '23', 'key': '10.1016/j.biomaterials.2008.04.036_bib184', 'first-page': '6831', 'article-title': 'Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors', 'volume': '62', 'author': 'Campbell', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors by Campbell (2002)
  185. 10.1016/S0168-3659(99)00248-5 / J Controlled Release / Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review by Maeda (2000)
  186. {'issue': '2', 'key': '10.1016/j.biomaterials.2008.04.036_bib186', 'first-page': '153', 'article-title': 'Long-circulating vectors for the systemic delivery of genes', 'volume': '3', 'author': 'Fenske', 'year': '2001', 'journal-title': 'Curr Opin Mol Ther'} / Curr Opin Mol Ther / Long-circulating vectors for the systemic delivery of genes by Fenske (2001)
  187. 10.1126/science.275.5301.820 / Science / Direct measurement of a tethered ligand–receptor interaction potential by Wong (1997)
  188. 10.3109/10611869909085493 / J Drug Target / Interactions between a macrophage cell line (J774A1) and surface-modified poly (d,l-lactide) nanocapsules bearing poly(ethylene glycol) by Mosqueira (1999)
  189. {'key': '10.1016/j.biomaterials.2008.04.036_bib189', 'series-title': "Caracterisation de nanocapsules lipidiques pegylées: application à l'encapsulation de complexes d'ADN", 'author': 'Vonarbourg', 'year': '2006'} / Caracterisation de nanocapsules lipidiques pegylées: application à l'encapsulation de complexes d'ADN by Vonarbourg (2006)
  190. 10.1177/153303460500400605 / Technol Cancer Res Treat / Long-circulating polymeric nanovectors for tumor-selective gene delivery by Kommareddy (2005)
  191. 10.1016/S0168-3659(01)00547-8 / J Controlled Release / Biodegradable poly(ethyleneimine) for plasmid DNA delivery by Ahn (2002)
  192. 10.1016/j.jconrel.2005.10.014 / J Controlled Release / Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells by Nimesh (2006)
  193. 10.1016/S0960-894X(00)00195-5 / Bioorg Med Chem Lett / Synthesis of glycosylated polyethylenimine with reduced toxicity and high transfecting efficiency by Leclercq (2000)
  194. 10.1021/bc025529v / Bioconjugate Chem / Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system by Petersen (2002)
  195. 10.1016/j.jconrel.2006.09.012 / J Controlled Release / PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice by Okuda (2006)
  196. 10.1089/10430349950016690 / Hum Gene Ther / Characterization of a targeted gene carrier, lactose–polyethylene glycol-grafted poly-l-lysine and its complex with plasmid DNA by Choi (1999)
  197. 10.1016/j.jconrel.2003.07.002 / J Controlled Release / A new antisense oligonucleotide delivery system based on self-assembled ODN–PEG hybrid conjugate micelles by Jeong (2003)
  198. 10.1002/(SICI)1097-0290(20000120)67:2<217::AID-BIT11>3.0.CO;2-Q / Biotechnol Bioeng / Design of imidazole-containing endosomolytic biopolymers for gene delivery by Pack (2000)
  199. 10.1089/hum.1998.9.12-1709 / Hum Gene Ther / Controlled gene delivery by DNA–gelatin nanospheres by Truong-Le (1998)
  200. 10.1080/10611860400013451 / J Drug Target / Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model by Kaul (2004)
  201. 10.1038/sj.cgt.7701041 / Cancer Gene Ther / Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors by Kommareddy (2007)
  202. 10.1016/0014-5793(96)00607-2 / FEBS Lett / Enhancement of the polycation-mediated DNA uptake and cell transfection with Pluronic P85 block copolymer by Astafieva (1996)
  203. 10.1016/S0304-3835(00)00629-7 / Cancer Lett / Improvement of gene transfer to cervical cancer cell lines using non-viral agents by Cho (2001)
  204. 10.1038/sj.gt.3301052 / Gene Ther / Evaluation of polyether–polyethyleneimine graft copolymers as gene transfer agents by Nguyen (2000)
  205. 10.1080/10611860290016711 / J Drug Target / Altered organ accumulation of oligonucleotides using polyethyleneimine grafted with poly(ethylene oxide) or Pluronic as carriers by Ochietti (2002)
  206. 10.1016/S0021-9797(02)00099-1 / J Colloid Interface Sci / Cross-linked polyvinylpyrrolidone nanoparticles: a potential carrier for hydrophilic drugs by Bharali (2003)
  207. 10.1016/j.biomaterials.2006.06.029 / Biomaterials / Ultra-low sized cross-linked polyvinylpyrrolidone nanoparticles as non-viral vectors for in vivo gene delivery by Saxena (2006)
  208. 10.1038/sj.gt.3300821 / Gene Ther / Stabilized plasmid–lipid particles: construction and characterization by Wheeler (1999)
  209. 10.1007/s11095-004-1873-z / Pharm Res / A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA by Jeffs (2005)
  210. 10.1038/nature04688 / Nature / RNAi-mediated gene silencing in non-human primates by Zimmermann (2006)
  211. 10.1038/sj.gt.3302777 / Gene Ther / A novel siRNA–lipoplex technology for RNA interference in the mouse vascular endothelium by Santel (2006)
  212. 10.1038/sj.gt.3302778 / Gene Ther / RNA interference in the mouse vascular endothelium by systemic administration of siRNA–lipoplexes for cancer therapy by Santel (2006)
  213. 10.1016/S0005-2736(00)00343-6 / Biochim Biophys Acta / Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures by Semple (2001)
  214. 10.1093/jnci/92.3.253 / J Natl Cancer Inst / Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects by Pagnan (2000)
  215. 10.1016/j.canlet.2004.11.065 / Cancer Lett / Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities by Brignole (2005)
  216. 10.1016/S0168-3659(97)00174-0 / J Controlled Release / Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier by Choi (1998)
  217. 10.1021/bc0340767 / Bioconjugate Chem / PEGylated polyethylenimine–Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells by Merdan (2003)
  218. 10.1016/S0168-3659(03)00230-X / J Controlled Release / Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes by Ogris (2003)
  219. 10.1002/(SICI)1521-2254(199905/06)1:3<210::AID-JGM30>3.0.CO;2-U / J Gene Med / Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI) by Erbacher (1999)
  220. 10.1080/10611860290016685 / J Drug Target / Development of long-circulating polyelectrolyte complexes for systemic delivery of genes by Oupicky (2002)
  221. 10.1038/sj.gt.3300965 / Gene Ther / Stabilized plasmid–lipid particles for regional gene therapy: formulation and transfection properties by Zhang (1999)
  222. 10.1016/S0005-2736(99)00059-0 / Biochim Biophys Acta / Stabilized plasmid–lipid particles: factors influencing plasmid entrapment and transfection properties by Mok (1999)
  223. 10.1016/j.bbamem.2005.02.001 / Biochim Biophys Acta / Stabilized plasmid–lipid particles containing PEG–diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression by Ambegia (2005)
  224. 10.1038/sj.gt.3301308 / Gene Ther / Stabilized plasmid–lipid particles for systemic gene therapy by Tam (2000)
  225. 10.1021/bc030028a / Bioconjugate Chem / Polyacetal–doxorubicin conjugates designed for pH-dependent degradation by Tomlinson (2003)
  226. 10.1016/S0168-3659(03)00099-3 / J Controlled Release / Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides by Murthy (2003)
  227. 10.1016/S0168-3659(03)00232-3 / J Controlled Release / Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids by Shin (2003)
  228. 10.1021/bc025625w / Bioconjugate Chem / Low-pH-sensitive PEG-stabilized plasmid–lipid nanoparticles: preparation and characterization by Choi (2003)
  229. {'issue': '20', 'key': '10.1016/j.biomaterials.2008.04.036_bib229', 'first-page': '6600', 'article-title': 'Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker', 'volume': '50', 'author': 'Greenfield', 'year': '1990', 'journal-title': 'Cancer Res'} / Cancer Res / Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker by Greenfield (1990)
  230. 10.1016/j.ymthe.2004.11.006 / Mol Ther / Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo by Walker (2005)
  231. {'issue': '5', 'key': '10.1016/j.biomaterials.2008.04.036_bib231', 'first-page': '337', 'article-title': 'Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes', 'volume': '1', 'author': 'Xu', 'year': '2002', 'journal-title': 'Mol Cancer Ther'} / Mol Cancer Ther / Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes by Xu (2002)
  232. 10.1089/hum.2005.16.57 / Hum Gene Ther / Tumor-specific gene delivery mediated by a novel peptide–polyethylenimine–DNA polyplex targeting aminopeptidase N/CD13 by Moffatt (2005)
  233. 10.1016/j.ijpharm.2006.02.027 / Int J Pharm / A folate receptor-targeted liposomal formulation for paclitaxel by Wu (2006)
  234. 10.1016/S0168-3659(01)00274-7 / J Controlled Release / Terplex DNA gene carrier system targeting artery wall cells by Yu (2001)
  235. 10.1038/sj.cgt.7700470 / Cancer Gene Ther / Identification of FGF receptor-binding peptides for cancer gene therapy by Maruta (2002)
  236. 10.1016/S0168-3659(00)00361-8 / J Controlled Release / Chitosan–DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency by Mao (2001)
  237. 10.1016/S0168-3659(01)00272-3 / J Controlled Release / Tumor targeting with surface-shielded ligand–polycation DNA complexes by Kircheis (2001)
  238. 10.1038/sj.cgt.7700487 / Cancer Gene Ther / Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity by Kircheis (2002)
  239. 10.1007/BF03401962 / Mol Med / Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv by Xu (2001)
  240. 10.1038/sj.gt.3302304 / Gene Ther / A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene by Yu (2004)
  241. 10.1093/nar/gnh140 / Nucleic Acids Res / Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle by Schiffelers (2004)
  242. 10.2741/wu2 / Front Biosci / Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications by Wu (2002)
  243. 10.1248/bpb.29.1521 / Biol Pharm Bull / Effect of the particle size of galactosylated lipoplex on hepatocyte-selective gene transfection after intraportal administration by Higuchi (2006)
  244. 10.1038/sj.gt.3301833 / Gene Ther / Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors by Reddy (2002)
  245. 10.1006/mthe.2002.0604 / Mol Ther / Folate-targeted gene transfer in vivo by Hofland (2002)
  246. 10.1021/bc0001488 / Bioconjugate Chem / Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery by Blessing (2001)
  247. 10.1038/sj.cgt.7700337 / Cancer Gene Ther / Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells by Li (2001)
  248. 10.1038/sj.gt.3302721 / Gene Ther / Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate by Moffatt (2006)
  249. 10.1002/(SICI)1520-6017(200004)89:4<499::AID-JPS7>3.0.CO;2-V / J Pharm Sci / Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates by Collard (2000)
  250. 10.1021/mp060039w / Mol Pharm / Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells by Li (2006)
  251. 10.1021/nl062395b / Nano Lett / Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells by Green (2007)
  252. 10.1155/S1110724303209074 / J Biomed Biotechnol / Transcriptional targeting in cancer gene therapy by Robson (2003)
  253. 10.1016/S0092-8674(00)81843-7 / Cell / Intercellular trafficking and protein delivery by a herpesvirus structural protein by Elliott (1997)
  254. 10.1016/0092-8674(88)90263-2 / Cell / Cellular uptake of the tat protein from human immunodeficiency virus by Frankel (1988)
  255. 10.1023/B:PHAM.0000041463.56768.ec / Pharm Res / Application of novel solid lipid nanoparticle (SLN)–gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo by Rudolph (2004)
  256. {'issue': '2', 'key': '10.1016/j.biomaterials.2008.04.036_bib256', 'first-page': '265', 'article-title': 'TAT peptide-modified liposomes for intracellular delivery of drugs and DNA', 'volume': '7', 'author': 'Torchilin', 'year': '2002', 'journal-title': 'Cell Mol Biol Lett'} / Cell Mol Biol Lett / TAT peptide-modified liposomes for intracellular delivery of drugs and DNA by Torchilin (2002)
  257. 10.1074/jbc.M007540200 / J Biol Chem / Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery by Futaki (2001)
  258. 10.1074/jbc.M110017200 / J Biol Chem / Possible existence of common internalization mechanisms among arginine-rich peptides by Suzuki (2002)
  259. 10.1074/jbc.272.25.16010 / J Biol Chem / A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus by Vives (1997)
  260. 10.1074/jbc.M006701200 / J Biol Chem / Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans by Tyagi (2001)
  261. 10.1038/nm996 / Nat Med / Transducible TAT–HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis by Wadia (2004)
  262. 10.1016/S1525-0016(03)00122-9 / Mol Ther / Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time by Ferrari (2003)
  263. 10.1074/jbc.M303045200 / J Biol Chem / Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins by Fittipaldi (2003)
  264. 10.1074/jbc.M209548200 / J Biol Chem / Cell-penetrating peptides: a reevaluation of the mechanism of cellular uptake by Richard (2003)
  265. 10.1016/S1359-6446(04)03042-9 / Drug Discov Today / The use of cell-penetrating peptides as a tool for gene regulation by Jarver (2004)
  266. 10.1016/S1471-4892(02)00199-6 / Curr Opin Pharmacol / Peptide-mediated cell delivery: application in protein target validation by Lindsay (2002)
  267. 10.1074/jbc.M401604200 / J Biol Chem / Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors by Richard (2005)
  268. 10.1089/108729002760070795 / Antisense Nucleic Acid Drug Dev / Cell-dependent differential cellular uptake of PNA, peptides, and PNA–peptide conjugates by Koppelhus (2002)
  269. 10.1089/hum.1997.8.17-2133 / Hum Gene Ther / Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer by Saeki (1997)
  270. 10.1016/S1357-4310(99)01482-3 / Mol Med Today / Gene therapy using HVJ–liposomes: the best of both worlds? by Kaneda (1999)
  271. 10.1016/j.jss.2005.09.027 / J Surg Res / Total vascular exclusion safely facilitates liver specific gene transfer by the HVJ (sendai virus)–liposome method in rats by Kawashita (2006)
  272. 10.1016/j.jconrel.2005.03.020 / J Controlled Release / Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release by Kunisawa (2005)
  273. 10.1016/S0169-409X(98)00005-2 / Adv Drug Deliv Rev / Application of membrane-active peptides for drug and gene delivery across cellular membranes by Plank (1998)
  274. 10.1073/pnas.89.17.7934 / Proc Natl Acad Sci U S A / Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin–polylysine–DNA complexes: toward a synthetic virus-like gene-transfer vehicle by Wagner (1992)
  275. 10.1021/bi00385a002 / Biochemistry / pH-dependent bilayer destabilization by an amphipathic peptide by Subbarao (1987)
  276. 10.1021/bi9618474 / Biochemistry / Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers by Wyman (1997)
  277. 10.1016/S0168-3659(98)00097-2 / J Controlled Release / Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery by MacLaughlin (1998)
  278. 10.1152/ajpcell.2000.278.6.C1063 / Am J Physiol Cell Physiol / Properties of cytotoxic peptide-formed ion channels by Kourie (2000)
  279. 10.1016/S0021-9258(18)99963-1 / J Biol Chem / The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems by Plank (1994)
  280. 10.1074/jbc.M108331200 / J Biol Chem / Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors by Ogris (2001)
  281. 10.1371/journal.pmed.0030006 / PLoS Med / EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice by Shir (2006)
  282. 10.1021/bc0255945 / Bioconjugate Chem / Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules by Rozema (2003)
  283. 10.1016/j.jconrel.2006.02.002 / J Controlled Release / Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexes by Boeckle (2006)
  284. 10.1021/bc060028l / Bioconjugate Chem / Gene transfer with poly-melittin peptides by Chen (2006)
  285. 10.1089/10430340050015482 / Hum Gene Ther / Photochemical transfection: a new technology for light-induced, site-directed gene delivery by Hogset (2000)
  286. 10.1038/nmat1524 / Nat Mater / Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer by Nishiyama (2005)
  287. 10.1016/j.ymthe.2006.02.003 / Mol Ther / Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization by Ndoye (2006)
  288. 10.1002/jgm.187 / J Gene Med / Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo by Wightman (2001)
  289. 10.1016/S0006-291X(03)00644-2 / Biochem Biophys Res Commun / Engineering nuclear localization signals in modular protein vehicles for gene therapy by Aris (2003)
  290. 10.1073/pnas.96.1.91 / Proc Natl Acad Sci U S A / Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus by Zanta (1999)
  291. 10.1016/j.jconrel.2005.02.019 / J Controlled Release / Optimization of nuclear localization signal for nuclear transport of DNA-encapsulating particles by Eguchi (2005)
  292. 10.1038/11726 / Nat Biotechnol / A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA by Branden (1999)
  293. 10.1016/j.jconrel.2006.02.008 / J Controlled Release / Development and in vitro validation of a targeted delivery vehicle for DNA vaccines by Talsma (2006)
  294. 10.1038/sj.gt.3302773 / Gene Ther / A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy by Moffatt (2006)
  295. 10.1016/j.ymthe.2005.10.007 / Mol Ther / Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems by Hama (2006)
  296. 10.1038/sj.gt.3302495 / Gene Ther / Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes by Varga (2005)
Dates
Type When
Created 17 years, 3 months ago (May 22, 2008, 8:53 a.m.)
Deposited 1 year, 5 months ago (Feb. 26, 2024, 10:49 a.m.)
Indexed 1 month, 4 weeks ago (June 25, 2025, 1:25 a.m.)
Issued 17 years ago (Aug. 1, 2008)
Published 17 years ago (Aug. 1, 2008)
Published Print 17 years ago (Aug. 1, 2008)
Funders 0

None

@article{Morille_2008, title={Progress in developing cationic vectors for non-viral systemic gene therapy against cancer}, volume={29}, ISSN={0142-9612}, url={http://dx.doi.org/10.1016/j.biomaterials.2008.04.036}, DOI={10.1016/j.biomaterials.2008.04.036}, number={24–25}, journal={Biomaterials}, publisher={Elsevier BV}, author={Morille, Marie and Passirani, Catherine and Vonarbourg, Arnaud and Clavreul, Anne and Benoit, Jean-Pierre}, year={2008}, month=aug, pages={3477–3496} }